Articles

Some hospitals, doctors might be cut from health plans

With health insurance premiums continuing to outstrip inflation, some health insurers and hospital systems are considering bringing back an old strategy: limiting patient access to a “narrow” network of doctors and hospitals.

Read More

STORY: Health care rationing has already arrived

There will be health care rationing. The only question is who will do the rationing—the government, health care providers, or you and me. The odds are good there will be some rationing from all those sources

Read More

BRODY: Accountable care organizations improve health care

As we began looking at accountable care organizations, we clearly understood that this new model complemented our existing approach and had potential to significantly affect care, leading to better communication, better coordination of care, and better outcomes for patients.

Read More

HARVEY: Dearth of faculty leading to nurse shortage

The looming shortage of nurses and the faculty to educate nurses threatens Americans’ access to quality health care. As our population ages and health care becomes more extensive and complex, an increasing demand for highly educated nurses persists. This need directly influences the necessity for nursing faculty.

Read More

WellPoint likely to go outside for chief

While WellPoint Inc. and its predecessors have a history of grooming new CEOs in-house, the next leader of the health insurance giant is likely to be an outsider, according to interviews with more than a half dozen former directors and officers of the company.

Read More

State drug fraud cases on the rise, study says

Federal and state prosecutors have collected more than $30 billion from drug companies for alleged fraud and illegal marketing over the last 20 years, according to a new report by consumer advocacy group Public Citizen.

Read More

Group aims to cut costs of late-stage drugs

You know things are bad in the fiercely competitive pharma industry when drugmakers start turning to each other for help. But that’s exactly what happened last week when 10 major drug companies—including Eli Lilly and Co.—joined forces to cut costs out of clinical trials.

Read More

Bill for Medicaid expansion? $516M a year

If Indiana expands its Medicaid program as called for under President Obama’s health reform law, it likely will hike state spending on the program an extra 13.5 percent—or $516 million annually—by 2020, according to the latest projections from Seattle-based actuarial firm Milliman Inc.

Read More

Lilly competitor Novo investing $100M in China

Novo Nordisk A/S, the world’s largest insulin maker, plans to spend $100 million on research in China. The move follows a similar one by Indianapolis-based Eli Lilly, which opened a 150-person research center in Shanghai in May.

Read More

Daniels’ health care team says answers pending

Indiana Gov. Mitch Daniels' team of federal health care overhaul leaders told state lawmakers Wednesday that even without clear answers on the new law, it will cost the state hundreds of millions more in the coming years.

Read More

High-deductible premiums rising, too

Since 2007, premiums for high-deductible health plans’ family coverage have grown 32 percent—compared with 30 percent among all health plans, according to survey data from the Kaiser Family Foundation.

Read More